|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Operating activities: | |||
| Net loss | |||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||
| Investment income earned on investments held in Trust Account | |||
| Prepaid expenses | |||
| Depreciation and amortization | |||
| Stock-based compensation | |||
| Non-cash lease expense | |||
| Accretion of discount on marketable securities | |||
| Transaction costs allocated to common stock warrants | |||
| Change in fair value of second lien loans | |||
| Change in fair value of simple agreements for future equity | |||
| Change in fair value of redeemable convertible preferred stock warrant liabilities | |||
| Redeemable convertible preferred stock warrants | |||
| Common stock warrants | |||
| Loss on issuance of equity instruments | |||
| Non-cash interest expense | |||
| Loss on disposal of property and equipment | |||
| Changes in operating assets and liabilities: | |||
| Accounts receivable | |||
| Prepaid expenses and other current assets | |||
| Other assets | |||
| Accounts payable | |||
| Accrued expenses and other current liabilities | |||
| Due to related party | |||
| Payment of formation costs through promissory note | |||
| Operating lease liabilities | |||
| Other liabilities | |||
| Net cash used in operating activities | |||
| Investing activities: | |||
| Cash deposited in Trust Account | |||
| Proceeds from maturities of marketable securities | |||
| Purchases of marketable securities | |||
| Purchases of property and equipment | |||
| Payment of deposits | |||
| Net cash (used in) provided by investing activities | |||
| Financing activities: | |||
| Gross proceeds | |||
| Proceeds received from sale of private placement warrants | |||
| Proceeds received from overfunding loans | |||
| Repayment of promissory note | |||
| Payment of underwriter and advisory fee | |||
| Payment of offering costs | |||
| Proceeds from the issuance of debt, net of issuance costs | |||
| Repayment of debt | |||
| Proceeds from issuance of second lien loans | |||
| Proceeds from issuance of simple agreements for future equity | |||
| Proceeds from exercise of stock options | |||
| Proceeds from exercise of common stock warrants | |||
| Payments for deferred offering costs | |||
| Net cash provided by financing activities | |||
| Net change in cash | |||
| Net change in cash and cash equivalents and restricted cash | |||
| Cash and cash equivalents and restricted cash at beginning of period | |||
| Cash and cash equivalents and restricted cash at end of period | |||
| Supplemental disclosure of cash activities: | |||
| Offering costs included in accrued expenses | |||
| Deferred offering costs paid by Sponsor through promissory note | |||
| Deferred underwriting and advisory fees | |||
| Cash paid for interest | |||
| Cash paid for income taxes | |||
| Supplemental disclosure of non-cash activities: | |||
| Purchases of property and equipment included in accounts payable and accrued expenses and other current liabilities | |||
| Operating lease right-of-use asset obtained in exchange for operating lease liability upon modification of operating lease | |||
| Operating lease right-of-use asset obtained in exchange for operating lease liability upon new operating lease | |||
| Proceeds from exercise of stock options included in prepaid and other current assets | |||
| Proceeds from exercise of common stock warrants included in prepaid and other current assets | |||
| Conversion of stock, amount converted | |||
| SAFE Conversion | |||
| Redeemable Preferred Stock Conversion | |||
| Conversion of second lien loans into common stock in connection with reverse recapitalization | |||
| Settlement of transaction costs in common stock in connection with reverse recapitalization | |||
| Exchange of simple agreements for future equity for second lien loan | |||
| Net exercise of warrants in connection with reverse recapitalization | |||
| Issuance of non-redemption common stock in connection with reverse recapitalization | |||
| Liabilities assumed from reverse recapitalization | |||
| Issuance of common stock in connection with a debt agreement | |||
| Components of cash and restricted cash at period end: | |||
| Cash and cash equivalents | |||
| Restricted cash |
Loading...